CGEM · Cullinan Therapeutics, Inc. · Executive Compensation

$20.59 -0.41 (-1.95%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$1.33B

64.35M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadim Ahmed	President and Chief Executive Officer	$698,476	—	$1,697,400	$2,234,340	$419,086	$50,704	$5,100,006
Jeffrey Jones	Chief Medical Officer	$529,804	—	$612,950	$806,845	$218,279	$53,700	$2,221,578
Mary Kay Fenton	Chief Financial Officer	$512,325	—	$565,800	$744,780	$211,898	$44,034	$2,078,837

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadim Ahmed	President and Chief Executive Officer	$674,856	—	$2,806,400	$3,704,160	$455,528	$43,422	$7,684,366
Mary Kay Fenton	Chief Financial Officer	$333,808	—	—	$3,598,260	$174,581	$35,764	$4,142,413
Jeffrey Trigilio	Former Chief Financial Officer	$123,396	$49,359	$1,498,687	$1,769,799	—	$561,193	$4,002,434
Jeffrey Jones	Chief Medical Officer	$511,888	—	$1,096,250	$1,446,938	$274,372	$58,566	$3,388,014

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadim Ahmed	President and Chief Executive Officer	$648,900	$389,340	$1,202,270	$1,645,420	—	$122,276	$4,008,206
Jeffrey Jones	Chief Medical Officer	$492,200	$236,256	$680,400	$960,948	—	$51,865	$2,421,669
Jeffrey Trigilio	Former Chief Financial Officer	$474,600	$404,811	$532,980	$748,739	—	$43,203	$2,204,333

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadim Ahmed	President and Chief Executive Officer	$618,000	$370,800	$2,762,750	—	—	$148,977	$3,900,527
Patrick Baeuerle	Chief Scientific Officer	$463,500	$266,234	$510,000	$686,250	—	$34,000	$1,959,984
Jeffrey Trigilio	Former Chief Financial Officer	$452,000	$260,352	$510,000	$686,288	—	$15,634	$1,924,274

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Nadim Ahmed	President and Chief Executive Officer	$125,000	$699,000	—	$37,723,200	—	—	$38,547,200
Owen Hughes	Former President and Chief Executive Officer	$433,279	$216,507	—	$6,005,982	—	$130,419	$6,786,187
Patrick Baeuerle	Chief Scientific Officer	$450,000	$218,000	—	$3,973,177	—	$34,800	$4,675,977
Jeffrey Trigilio	Chief Financial Officer	$400,000	$220,000	—	$2,032,777	—	$14,858	$2,667,635

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Owen Hughes	Former President and Chief Executive Officer	$461,250	$245,063	$530,320	$5,301,175	—	$14,250	$6,552,058
Patrick Bauerle	Acting Chief Scientific Officer, Biologics	$436,997	$266,131	$491,284	$4,124,284	—	$34,800	$5,353,497
Patrick Baeuerle	Ph.D., Acting Chief Scientific Officer	$436,997	$266,131	$491,284	$4,124,284	—	$34,800	$5,353,496
Jon Wigginton	Chief Medical Officer	$321,122	$258,000	—	$3,959,525	—	$5,375	$4,544,022

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Patrick Bauerle	Acting Chief Scientific Officer, Biologics	$420,895	$107,502	—	—	—	$34,400	$562,797
Owen Hughes	Chief Executive Officer	$450,000	$96,800	—	—	—	$14,000	$560,800

Executive changes

Person	Role	Change	Effective	Filed
Andrew Allen	Class II director	Appointed	2025-08-07	2025-08-07
Mittie Doyle	Class I director	Appointed	2025-08-07	2025-08-07
David P. Ryan	director	Resigned	2025-08-07	2025-08-07
Anne-Marie Martin	director	Resigned	2025-08-07	2025-08-07

Key facts CIK 1789972 CUSIP 230031106 13F (30d) 65 filings 65 filers Visit website Investor relations